Skip to main content
. Author manuscript; available in PMC: 2020 Mar 15.
Published in final edited form as: Life Sci. 2019 Feb 2;221:29–34. doi: 10.1016/j.lfs.2019.01.043

Fig. 2.

Fig. 2.

Atorvastatin prevents aldosterone-induced Rac1/2 activity in WKY VSMCs. Effects of aldosterone (10−7 mol/L) on Rac1/2 translocation from cytosol to the membrane, in the absence and presence of 10−7 mol/L of atorvastatin (60 minutes and 72 hours pre-incubation). Representative immunoblots: Rac1/2 (fractions of membrane and cytosol). Results are mean ± SEM of 5–6 experiments. *P < 0.05, vs. vehicle.